1392P Safety and efficacy of crizotinib in MET mutated (METmut) advanced non-small cell lung Cancer (aNSCLC): Results from the Drug Rediscovery Protocol (DRUP)
| Autor: | Verkerk, K., van der Wel, T., Zeverijn, L.J., Geurts, B.S., Spiekman, I.A.C., de Wit, G.F., Roepman, P., Jansen, A., van der Noort, V., Smit, E.F., Hoeben, A., Hendriks, L., Van Herpen, C.M.L., Piet, B., Herder, G., Hashemi, S.M.S., Gelderblom, H., Verheul, H.M.W., Voest, E.E., De Langen, J. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S797-S798 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|